School of Pharmacy and Biomolecular Sciences, Liverpool John Moores, Liverpool, UK.
Pharma Nord (UK) Ltd, Morpeth, Newcastle, UK.
Adv Exp Med Biol. 2019;1178:103-112. doi: 10.1007/978-3-030-25650-0_6.
Coenzyme Q10 (CoQ10) is a vitamin-like substance which functions as an electron carrier within the mitochondrial respiratory chain, as well as serving as an important intracellular antioxidant. Most of the body's CoQ10 requirements are met by endogenous synthesis, although the capacity for CoQ10 production decreases substantially with increasing age. In this article we have reviewed the potential role of CoQ10 supplementation in the treatment of tissue fibrosis, which has been implicated in the age-related loss of function of various organs including the heart. Clinical studies have indicated that CoQ10 supplementation may decrease the level of cardiovascular fibrosis to which older individuals are subjected, and thereby improve cardiovascular function and reduce the risk of cardiovascular associated mortality. Although the factors responsible for the anti-fibrotic action of CoQ10 have yet to be fully elucidated, its antioxidant and anti-inflammatory functions are thought to be major contributors to its clinical efficacy in the treatment of this age-related disorder.
辅酶 Q10(CoQ10)是一种类维生素物质,它在 线粒体呼吸链中作为电子载体发挥作用,同时也是一种重要的细胞内抗氧化剂。虽然 随着年龄的增长,CoQ10 的产生能力会大幅下降,但身体的大部分 CoQ10 需求都是通过内源性合成来满足的。在本文中,我们综述了 CoQ10 补充剂在治疗组织纤维化中的潜在作用,组织纤维化与包括心脏在内的各种器官的与年龄相关的功能丧失有关。临床研究表明,CoQ10 补充剂可能降低老年个体易患的心血管纤维化水平,从而改善心血管功能并降低与心血管相关的死亡率。尽管 CoQ10 抗纤维化作用的相关因素尚未完全阐明,但它的抗氧化和抗炎功能被认为是其在治疗这种与年龄相关疾病的临床疗效中的主要贡献因素。